Showing results (51-60 of 234) with videos related to

Sort By:
Pageof 24
Antimicrobial Agents and Chemotherapy|May 15, 2013
Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposureRyan K Shields, M Hong Nguyen, Ellen G Press, et al.
Antimicrobial Agents and Chemotherapy|February 23, 2017
Mutations in blaKPC-3 That Confer Ceftazidime-Avibactam Resistance Encode Novel KPC-3 Variants That Function as Extended-Spectrum β-LactamasesGhady Haidar, Cornelius J Clancy, Ryan K Shields, et al.
Open Forum Infectious Diseases|April 23, 2021
Candida Empyema Thoracis at Two Academic Medical Centers: New Insights Into Treatment and OutcomesSuheyla S Senger, George R Thompson, Palash Samanta, et al.
International Journal of Antimicrobial Agents|January 25, 2008
A pharmacokinetic/pharmacodynamic mathematical model accurately describes the activity of voriconazole against Candida spp. in vitroYanjun Li, M Hong Nguyen, Shaoji Cheng, et al.
Eukaryotic Cell|March 3, 2009
Candida albicans RFX2 encodes a DNA binding protein involved in DNA damage responses, morphogenesis, and virulenceBinghua Hao, Cornelius J Clancy, Shaoji Cheng, et al.
Annals of the American Thoracic Society|August 23, 2014
Emerging and resistant infectionsCornelius J Clancy, Andre C Kalil, Vance G Fowler, et al.
Microbiology (Reading, England)|September 10, 2005
Candida albicans IRS4 contributes to hyphal formation and virulence after the initial stages of disseminated candidiasisHassan Badrane, Shaoji Cheng, M Hong Nguyen, et al.
Pageof 24